New onset diabetes mellitus after solid organ transplantation.
This article presents an overview of the literature on the current diagnostic criteria for new onset diabetes mellitus after transplantation (NODAT) and discusses suggested risk factors for the development of NODAT, its potential pathogenic mechanisms, and its impact on post-transplant outcomes after solid organ transplantation. Suggested guidelines for early identification and management of NODAT are also discussed.
Pham
Phuong-Thu T
PT
Kidney and Pancreas Transplantation, Department of Medicine, University of California, Los Angeles, CA 90095-1693, USA.
Pham
Phuong-Chi T
PC
Lipshutz
Gerald S
GS
Wilkinson
Alan H
AH
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D065095:Calcineurin Inhibitors; D003586:Cytomegalovirus Infections / Q000150:complications; D003920:Diabetes Mellitus / Q000209:etiology*; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D014184:Transplantation, Homologous
D000305:Adrenal Cortex Hormones; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents